FibroGen Inc (OQ:FGEN)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for FGEN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,000  
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -12,000  
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Common Stock S - Open market or private sale -18,000 $23.17
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,000 $2.90
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -830 $25.32
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -300 $23.93
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,345 $25.40
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,345  
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -6,215 $26.08
Mar 19/20 Mar 18/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -1,500 $25.68
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for FGEN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,000  
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -12,000  
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Common Stock S - Open market or private sale -18,000 $23.17
Mar 23/20 Mar 19/20 Kearns Thomas F Jr Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 18,000 $2.90
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -830 $25.32
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -300 $23.93
Mar 19/20 Mar 19/20 Chung Christine Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,345 $25.40
Mar 19/20 Mar 18/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -1,500 $25.68
Mar 19/20 Mar 18/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -1,500 $24.56
Mar 19/20 Mar 18/20 Chung Christine Direct Ownership Common Stock S - Open market or private sale -905 $23.69
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $FGEN

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)